30 June 2025
30 June 2025
The agency stated that REMS requirements can be removed because safety and effectiveness are assured without them.
Torrent intends to buy 2.8% of equity shares from JB employees at the same price per share as offered to KKR.
The FDA approval was based on the pooled data from two pivotal studies: the EMERALD trial and NI-0501-06.
Viatris will handle all development and commercialisation aspects of Yupelri in the Chinese market.
As AI-designed drugs begin to enter clinical trials, can it truly deliver on its promise to transform pharmaceutical R&D?
The collaboration will establish a platform for leukaemia and other cancer treatments within the Middle East and Africa.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
